Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance
about
Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysisBlood cells: an historical account of the roles of purinergic signallingAspirin resistance: current status and role of tailored therapyAcetylsalicylic acid resistance and clinical outcome--the Hobikoglu study is worth notingAgonist-inducible platelet activation in chronic idiopathic autoimmune thrombocytopenia.Antiplatelet and anticoagulant drugs in interventional radiology.Frequency of heparin/platelet factor 4-dependent platelet antibodies in patients undergoing angioplasty and stenting for cardiovascular disease and their role for on-clopidogrel platelet reactivity.Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance--the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapyCyclooxygenase expression and platelet function in healthy dogs receiving low-dose aspirinImplementing genotype-guided antithrombotic therapy.Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart studyAspirin resistance: Fact or fiction? A point of view.Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations.Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac CatheterizationIncreased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapyDifferences in Whole Blood Platelet Aggregation at Baseline and in Response to Aspirin and Aspirin Plus Clopidogrel in Patients With Versus Without Chronic Kidney Disease.Time-dependent changes in non-COX-1-dependent platelet function with daily aspirin therapy.Modification of Pulsed Electric Field Conditions Results in Distinct Activation Profiles of Platelet-Rich PlasmaInteraction among COX-2, P2Y1 and GPIIIa gene variants is associated with aspirin resistance and early neurological deterioration in Chinese stroke patients.Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patientsPharmacogenomics of platelet responsiveness to aspirin.Pharmacogenetics of aspirin resistance: a comprehensive systematic review.Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over studyUpdate on oral antiplatelet therapy: principles, problems and promises.Cangrelor: a novel P2Y12 receptor antagonist.Aspirin resistance in patients with type II diabetes mellitus.Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.Interactions among COX-2, GPIIIa and P2Y1 variants are associated with aspirin responsiveness and adverse events in patients with ischemic stroke.Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease.Functional testing methods for the antiplatelet effects of aspirin.The pharmacogenetics of antiplatelet agents: towards personalized therapy?A contemporary viewpoint on 'aspirin resistance'.Advances in monitoring of aspirin therapy.Overcoming aspirin treatment failure in diabetes.Monitoring aspirin and clopidogrel response: testing controversies and recommendations.Genetics of platelet inhibitor treatmentAspirin resistance: a clinical review focused on the most common cause, noncompliance.Cardiovascular pharmacology core reviews: aspirin.Contemporary antiplatelet therapy in patients undergoing percutaneous coronary intervention.Clopidogrel improves aspirin response after off-pump coronary artery bypass surgery
P2860
Q24645413-31367742-75D2-4DA1-9E6D-9AB63CADC126Q26799623-45A14340-D2A9-497A-B602-C67C15C0F3B3Q26851367-EBC02337-04C4-4C1D-B8F6-B9304AEF7EF1Q28220410-4DABA6D4-A4C2-4F72-A740-5ABEA652AE05Q33376011-CC2AEB94-D88E-4844-ABB3-C0C7D3775603Q33395898-B04634CD-9410-483D-B9B5-D4BAE0CAF822Q33399119-A8B90C03-A9AD-4812-B149-DC035A738E1EQ33791290-ABC0072F-92E2-4C8D-ADA6-53DE4BB34737Q33837587-F79BD48E-50A0-464A-8740-271CF45D3CE7Q33990428-340EAC4B-E54F-472F-B36D-7AFE18DEF2F1Q34023032-441E9FD2-E0DA-4CC3-A90C-083D3C689840Q34389630-E7330506-9641-4519-9B1E-BE744C60287AQ35373683-A388ECAA-46C1-4DD3-B292-3D822788DB2EQ35735264-14F76EC4-64B3-463B-B84A-F0BF5EA4602AQ35755253-29247165-16A4-46E7-A839-62E46D36FAFBQ35883494-FBCE5B09-305B-4520-AE4B-88E168C68E01Q35916268-34870F16-434B-4059-815B-498C91AA7771Q36111366-ACB89D45-A370-4DC9-929E-3410BF5C4782Q36244656-D4C4C4AA-1F44-485D-A899-9370AC9338CAQ36881941-117A613E-3135-4977-9093-917AF96E88D9Q36989841-E8615C7B-FBD8-463D-A239-A0A3D37F6B58Q37145122-A957E940-623C-4D4E-8CA0-D54D7292AA80Q37234897-053499E9-97C2-4C49-BFD8-53730BC15ACBQ37486605-1EB3F6B8-EFBE-4FF8-998D-382D93C6E940Q37551923-945494FA-72B9-4F23-8BF7-EFD93E8D00E8Q37564161-6072E057-EFC7-48CA-B33A-042A36C7750AQ37629641-AB2994DD-5644-4DC3-9385-DA0F1E6041E8Q37698588-BDA219E2-EAD7-4098-B303-F25C57717AEFQ37797795-DDCC6CB6-1D67-49AC-831D-F4727703D036Q37841562-472C78BB-2A52-4EB0-A0D6-322C903F7441Q37913976-49627857-F053-4B65-AF66-380FDDB80AEDQ37989558-0B159C96-78BC-456D-943E-D7C949179E3DQ38032895-F31766E1-189F-41B8-B3E8-3B5BABA0D839Q38055245-E587FE72-6EEB-476D-B7CB-CF66D9850943Q38099235-EDB7CD13-71D6-445D-AD79-851483F59ED5Q38131848-5B898157-9F8B-4A1A-8EE7-61813CE83B88Q38132148-C1E7E5B0-8751-4001-BF75-71E1C78AEEA3Q38140795-BE456EFC-BC74-40D7-8E76-B8CAB2E0FDDCQ38197732-15498BE2-09E2-44F5-8DA8-9DBC801ABF97Q38543604-EF33B8E4-3775-4C93-AC03-587FE0C5F734
P2860
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Residual arachidonic acid-indu ...... nt study of aspirin resistance
@ast
Residual arachidonic acid-indu ...... nt study of aspirin resistance
@en
Residual arachidonic acid-indu ...... nt study of aspirin resistance
@nl
type
label
Residual arachidonic acid-indu ...... nt study of aspirin resistance
@ast
Residual arachidonic acid-indu ...... nt study of aspirin resistance
@en
Residual arachidonic acid-indu ...... nt study of aspirin resistance
@nl
prefLabel
Residual arachidonic acid-indu ...... nt study of aspirin resistance
@ast
Residual arachidonic acid-indu ...... nt study of aspirin resistance
@en
Residual arachidonic acid-indu ...... nt study of aspirin resistance
@nl
P2093
P3181
P1433
P1476
Residual arachidonic acid-indu ...... nt study of aspirin resistance
@en
P2093
Alan D Michelson
Andrew L Frelinger
Marc R Barnard
Mark I Furman
Marsha L Fox
P304
P3181
P356
10.1161/CIRCULATIONAHA.105.596627
P407
P577
2006-06-19T00:00:00Z